10jili login registration

10jili login registration NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 18, 2025 in the securities class action first filed by the Firm. SO WHAT: If you purchased Kaspi.kz securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Kaspi.kz class action, go to https://rosenlegal.com/submit-form/?case_id=29172 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 18, 2025 . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Kaspi.kz continued doing business with Russian entities, and also providing services to Russian citizens, after Russia’s 2022 invasion of Ukraine, thereby exposing Kaspi.kz to the undisclosed risk of sanctions; (2) Kaspi.kz engaged in undisclosed related party transactions; (3) certain of Kaspi.kz’s executives have links to reputed criminals; and (4) as a result, defendants’ statements about Kaspi.kz’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Kaspi.kz class action, go to https://rosenlegal.com/submit-form/?case_id=29172 call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm . Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40 th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com

Daniel Jones Released by Giants, Eyes New Opportunity Elsewhere

Article content Amber Heard is weighing in on Blake Lively’s sexual harassment complaint against Justin Baldoni. Last week, Lively, 37, accused her It Ends With Us director and co-star Baldoni, 40, of harassment during the making the movie, which adapted Colleen Hoover’s bestselling 2016 novel and explores themes of domestic violence and emotional abuse. In the complaint, which was obtained by the Associated Press and the New York Times , Lively alleged that Baldoni and his production company embarked on a “multi-tiered plan” to damage her reputation after a meeting in which she and her husband Ryan Reynolds addressed “repeated sexual harassment and other disturbing behaviour” during the making of the film. Baldoni has denied the claims and hired the same crisis manager Heard’s ex-husband, Johnny Depp, did during the former couple’s highly publicized 2022 defamation lawsuit, which he won. But Heard said Baldoni’s hiring of Depp’s former PR representative Melissa Nathan of The Agency Group reminds her of her own legal battle against her ex that played out in a Virginia courtroom more than two years ago. In an exclusive statement shared with NBC News , Heard, who moved to Spain following the trial, said: “Social media is the absolute personification of the classic saying ‘A lie travels halfway around the world before truth can get its boots on.’ I saw this firsthand and up close. It’s as horrifying as it is destructive.” According to the Washington Post , Lively’s complaint alleges that Baldoni “flouted intimacy protocols on set, improvising kisses in scenes without an intimacy coordinator present and trying to add sexual or nude scenes she found unnecessary.” When they weren’t shooting, the complaint goes on to add that Baldoni “made sexual comments objectifying her and other actresses on set, and entered her trailer while she was undressed.” The complaint goes on to accuse Baldoni of orchestrating a campaign to discredit her during the film’s rocky promotional tour this past summer, which included trying to drum up headlines to push the narrative that Lively had a “less than favourable reputation.” Anticipating that Lively might go public with her complaints when the film was in theatres, Baldoni’s personal publicist allegedly texted Nathan to ask that she ramp up an online campaign to discredit Lively. “I think you guys need to be tough and show the strength of what you guys can do in these scenarios,” the Post quotes his publicist as texting to Nathan. “He wants to feel like she can be buried.” According to the Post , Lively accuses Nathan’s production company, Wayfarer Studios, of working with a subcontractor and his “digital army” to help “create and sustain a negative news cycle and social media algorithm” about her. “The Baldoni-Wayfarer team would then feed pieces of this manufactured content to unwitting reporters, making content go viral in order to influence public opinion and thereby cause an organic pile-on,” Lively’s complaint alleges. “The effects on Ms. Lively’s professional life were immediate and substantial,” the complaint reads. “Given the ongoing nature of the campaign and the associated negative public sentiment, Ms. Lively did not believe she could proceed with public appearances or events without being forced to openly discuss what happened on set.” While Lively plugged the film as a romantic drama, the complaint says Baldoni “used domestic violence ‘survivor content’ to protect his public image.” The press tour for the film, which was a summertime box office hit, was plagued by rumours of infighting between Baldoni and the rest of the cast. At various red carpet events promoting its release, Baldoni and Lively weren’t photographed together. On the red carpet with E! News , Lively said that Reynolds was very involved in It Ends With Us , and adapted a pivotal moment in the film. “The iconic rooftop scene in this movie, my husband wrote it. Nobody knows that,” she said. The film’s credited screenwriter, Christy Hall, told PEOPLE that she thought the actors were improvising. Additionally, according to The Hollywood Reporter , Lively sought to have her own edit of the movie, which was overseen by Shane Reid, who also worked on her Reynolds’ Deadpool & Wolverine . But Lively’s promotion of the movie hit a sour note with some moviegoers after she appeared on the official It Ends With Us TikTok page, touting the film in a lighthearted manner. “Grab your friends, wear your florals and head out to see it,” she said. Norwegian journalist Kjersti Flaa fanned more backlash when she reshared an old interview with Lively that went viral, which she titled: “ The Blake Lively interview that made me want to quit my job. ” Flaa called Lively’s “dismissive” demeanor during their 2016 sit-down was “the most uncomfortable interview situation I have ever experienced.” “There are conspiracy theories out there accusing me of being paid by his PR team to help with their smear campaign. None of this is true,” Flaa said in an Instagram post . Meanwhile, Baldoni – who has been dropped by his talent agency, WME in the wake of the claims – promoted the project by highlighting his commitment to raising awareness about domestic violence. “If a Lily Bloom in real life can sit in this theater, and make a different choice for herself than the one that was made for her, maybe she sees herself on that screen and chooses something different for herself,” Baldoni said in a red carpet interview with Entertainment Tonight. On Monday, Baldoni’s lawyer Bryan Freedman addressed Lively’s claims that his client’s publicity team wrecked havoc with her career and damaged her reputation. “TAG PR operated as any other crisis management firm would when hired by a client experiencing threats by two extremely powerful people with unlimited resources,” Freedman told PEOPLE . Freedman went on to add that audiences ended up concluding that “Lively’s own actions, interviews and marketing during the promotional tour (were) distasteful, and responded organically to that.” But Lively has been supported by Hoover, who took to her Instagram Story praise the actress as “nothing but honest, kind, supportive and patient since the day we met.” Lively’s A Simple Favor director Paul Feig has also publicly backed her. “I’ve now made two movies with Blake and all I can say is she’s one of the most professional, creative, collaborative, talented and kind people I’ve ever worked with,” Feig shared on X. Sony Pictures, which released It Ends With Us , has also sided with Lively. “We have previously expressed our support for Blake in connection with her work on and for the film. We fully and firmly reiterate that support today,” they said in a statement to Variety . mdaniell@postmedia.com

Darius Tahir | (TNS) KFF Health News President-elect Donald Trump’s choice to run the sprawling government agency that administers Medicare, Medicaid, and the Affordable Care Act marketplace — celebrity doctor Mehmet Oz — recently held broad investments in health care, tech, and food companies that would pose significant conflicts of interest. Oz’s holdings, some shared with family, included a stake in UnitedHealth Group worth as much as $600,000, as well as shares of pharmaceutical firms and tech companies with business in the health care sector, such as Amazon. Collectively, Oz’s investments total tens of millions of dollars, according to financial disclosures he filed during his failed 2022 run for a Pennsylvania U.S. Senate seat. Trump said Tuesday he would nominate Oz as administrator of the Centers for Medicare & Medicaid Services. The agency’s scope is huge: CMS oversees coverage for more than 160 million Americans, nearly half the population. Medicare alone accounts for approximately $1 trillion in annual spending, with over 67 million enrollees. UnitedHealth Group is one of the largest health care companies in the nation and arguably the most important business partner of CMS, through which it is the leading provider of commercial health plans available to Medicare beneficiaries. UnitedHealth also offers managed-care plans under Medicaid, the joint state-federal program for low-income people, and sells plans on government-run marketplaces set up via the Affordable Care Act. Oz also had smaller stakes in CVS Health, which now includes the insurer Aetna, and in the insurer Cigna. It’s not clear if Oz, a heart surgeon by training, still holds investments in health care companies, or if he would divest his shares or otherwise seek to mitigate conflicts of interest should he be confirmed by the Senate. Reached by phone on Wednesday, he said he was in a Zoom meeting and declined to comment. An assistant did not reply to an email message with detailed questions. “It’s obvious that over the years he’s cultivated an interest in the pharmaceutical industry and the insurance industry,” said Peter Lurie, president of the Center for Science in the Public Interest, a watchdog group. “That raises a question of whether he can be trusted to act on behalf of the American people.” (The publisher of KFF Health News, David Rousseau, is on the CSPI board .) Oz used his TikTok page on multiple occasions in November to praise Trump and Robert F. Kennedy Jr., including their efforts to take on the “illness-industrial complex,” and he slammed “so-called experts like the big medical societies” for dishing out what he called bad nutritional advice. Oz’s positions on health policy have been chameleonic; in 2010, he cut an ad urging Californians to sign up for insurance under President Barack Obama’s Affordable Care Act, telling viewers they had a “historic opportunity.” Oz’s 2022 financial disclosures show that the television star invested a substantial part of his wealth in health care and food firms. Were he confirmed to run CMS, his job would involve interacting with giants of the industry that have contributed to his wealth. Given the breadth of his investments, it would be difficult for Oz to recuse himself from matters affecting his assets, if he still holds them. “He could spend his time in a rocking chair” if that happened, Lurie said. In the past, nominees for government positions with similar potential conflicts of interest have chosen to sell the assets or otherwise divest themselves. For instance, Treasury Secretary Janet Yellen and Attorney General Merrick Garland agreed to divest their holdings in relevant, publicly traded companies when they joined the Biden administration. Trump, however, declined in his first term to relinquish control of his own companies and other assets while in office, and he isn’t expected to do so in his second term. He has not publicly indicated concern about his subordinates’ financial holdings. CMS’ main job is to administer Medicare. About half of new enrollees now choose Medicare Advantage, in which commercial insurers provide their health coverage, instead of the traditional, government-run program, according to an analysis from KFF, a health information nonprofit that includes KFF Health News. Proponents of Medicare Advantage say the private plans offer more compelling services than the government and better manage the costs of care. Critics note that Medicare Advantage plans have a long history of costing taxpayers more than the traditional program. UnitedHealth, CVS, and Cigna are all substantial players in the Medicare Advantage market. It’s not always a good relationship with the government. The Department of Justice filed a 2017 complaint against UnitedHealth alleging the company used false information to inflate charges to the government. The case is ongoing. Oz is an enthusiastic proponent of Medicare Advantage. In 2020, he proposed offering Medicare Advantage to all; during his Senate run, he offered a more general pledge to expand those plans. After Trump announced Oz’s nomination for CMS, Jeffrey Singer, a senior fellow at the libertarian-leaning Cato Institute, said he was “uncertain about Dr. Oz’s familiarity with health care financing and economics.” Singer said Oz’s Medicare Advantage proposal could require large new taxes — perhaps a 20% payroll tax — to implement. Oz has gotten a mixed reception from elsewhere in Washington. Pennsylvania Sen. John Fetterman, the Democrat who defeated Oz in 2022, signaled he’d potentially support his appointment to CMS. “If Dr. Oz is about protecting and preserving Medicare and Medicaid, I’m voting for the dude,” he said on the social platform X. Oz’s investments in companies doing business with the federal government don’t end with big insurers. He and his family also hold hospital stocks, according to his 2022 disclosure, as well as a stake in Amazon worth as much as nearly $2.4 million. (Candidates for federal office are required to disclose a broad range of values for their holdings, not a specific figure.) Amazon operates an internet pharmacy, and the company announced in June that its subscription service is available to Medicare enrollees. It also owns a primary care service , One Medical, that accepts Medicare and “select” Medicare Advantage plans. Oz was also directly invested in several large pharmaceutical companies and, through investments in venture capital funds, indirectly invested in other biotech and vaccine firms. Big Pharma has been a frequent target of criticism and sometimes conspiracy theories from Trump and his allies. Kennedy, whom Trump has said he’ll nominate to be Health and Human Services secretary, is a longtime anti-vaccine activist. During the Biden administration, Congress gave Medicare authority to negotiate with drug companies over their prices. CMS initially selected 10 drugs. Those drugs collectively accounted for $50.5 billion in spending between June 1, 2022, and May 31, 2023, under Medicare’s Part D prescription drug benefit. At least four of those 10 medications are manufactured by companies in which Oz held stock, worth as much as about $50,000. Related Articles National Politics | Special counsel moves to dismiss election interference, classified documents cases against Trump National Politics | Donald Trump Jr. emerges as a political force of his own as he helps his father launch a second term National Politics | The rising price of paying the national debt is a risk for Trump’s promises on growth and inflation National Politics | What to know about Brooke Rollins, Trump’s pick for agriculture secretary National Politics | After Trump’s Project 2025 denials, he is tapping its authors and influencers for key roles Oz may gain or lose financially from other Trump administration proposals. For example, as of 2022, Oz held investments worth as much as $6 million in fertility treatment providers. To counter fears that politicians who oppose abortion would ban in vitro fertilization, Trump floated during his campaign making in vitro fertilization treatment free. It’s unclear whether the government would pay for the services. In his TikTok videos from earlier in November, Oz echoed attacks on the food industry by Kennedy and other figures in his “Make America Healthy Again” movement. They blame processed foods and underregulation of the industry for the poor health of many Americans, concerns shared by many Democrats and more mainstream experts. But in 2022, Oz owned stakes worth as much as $80,000 in Domino’s Pizza, Pepsi, and US Foods, as well as more substantial investments in other parts of the food chain, including cattle; Oz reported investments worth as much as $5.5 million in a farm and livestock, as well as a stake in a dairy-free milk startup. He was also indirectly invested in the restaurant chain Epic Burger. One of his largest investments was in the Pennsylvania-based convenience store chain Wawa, which sells fast food and all manner of ultra-processed snacks. Oz and his wife reported a stake in the company, beloved by many Pennsylvanians, worth as much as $30 million. ©2024 KFF Health News. Distributed by Tribune Content Agency, LLC.